Tatia Global Venture Limited has formally notified the Bombay Stock Exchange about its upcoming board meeting scheduled for February 05, 2026. The meeting represents a significant milestone as the 5th Board of Directors meeting for the financial year 2025-26, demonstrating the company's commitment to regular governance and regulatory compliance.

Meeting Details and Venue

The board meeting will convene at 04:00 PM on Thursday, February 05, 2026, at the company's registered office located at New No. 29, Old No. 12, Mookathal Street, IInd Floor, Purasawalkam, Chennai - 600007. This timing and venue selection ensures accessibility for all board members while maintaining the formal corporate governance structure.

Key Agenda Items

The board meeting will address two primary business matters of significant importance to stakeholders:

Trading Window Restrictions

In accordance with regulatory protocols, Tatia Global Venture Limited has implemented trading window restrictions to ensure fair market practices. The trading window for dealing in the company's securities was closed from January 01, 2026, and will remain closed until 48 hours after the declaration of unaudited financial results. This measure aligns with standard market practices and regulatory requirements under SEBI guidelines.

Regulatory Compliance Framework

The board meeting notification has been issued in pursuance of Regulation 29 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This demonstrates the company's adherence to transparency requirements and commitment to keeping stakeholders informed about material corporate developments. The formal communication was signed by Madhur Agarwal, Company Secretary and Compliance Officer, on January 28, 2026.

Tatia Global Vennture Limited, a company listed on the Bombay Stock Exchange (BSE: 521228), has reported the withdrawal of a civil suit filed against it by a client, Dr. Karikkassery Thomas Joseph Rajan. The company disclosed this information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Details of the Civil Suit

The civil suit, numbered C.S. No. 156 of 2024, was filed before the High Court of Judicature. The plaintiff, Dr. Karikkassery Thomas Joseph Rajan, had sought the following reliefs:

1. A direction for the company to pay a sum of Rs. 1,15,23,008.00
2. Interest at 18% per annum on the above amount from the date of filing the plaint until the date of decree, and thereafter at the same rate until realization
3. Payment of legal costs associated with the suit

Withdrawal and Dismissal

According to the company's disclosure, the plaintiff sought permission from the court to withdraw the suit. Consequently, the High Court of Judicature passed an order on June 26, 2025, dismissing the case as withdrawn.

Regulatory Compliance

Tatia Global Vennture Limited demonstrated its commitment to regulatory compliance by adhering to the following timeline:

In its communication to the BSE, the company emphasized that there was no delay in submitting the disclosure to the exchange, as it was done within the stipulated 24-hour timeframe.

Company's Statement

Madhur Agarwal, Company Secretary and Compliance Officer of Tatia Global Vennture Limited, signed the regulatory filing, confirming the details of the case withdrawal and the company's timely disclosure.

This development marks the resolution of a potential legal challenge for Tatia Global Vennture Limited, with the withdrawal of the civil suit alleviating concerns about the claimed financial liability and associated legal proceedings.